Global Topical Drug Delivery Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Topical Drug Delivery Market, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products), Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), Distribution Channel (Direct Tenders, Retail), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Topical Drug Delivery Market Market Analysis and Insights : Global Topical Drug Delivery Market

The topical drug delivery market is expected to witness market growth at a rate of 7.45% in the forecast period of 2021 to 2028. Data Bridge Market Research report on topical drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of skin and soft tissue infections is escalating the growth of topical drug delivery market.

Topical drug delivery is known to be one of the most effective ways of drug delivery owning to its optimum therapeutic results. The desired therapeutic effect and the undesired unfavorable effect of a drug are dependent on the concentration of the drug at the place of action. The concentration of the drug is in accordance with the dosage form and the extent of absorption of the drug at the site of action.

The increasing incidences of skin infections such as eczema, psoriasis among others and minor ailments including acne act as one of the major factors driving the growth of topical drug delivery market. The preference towards administration of drugs through the skin with the purpose of controlling or prolonging drug delivery and the use of this process as an alternative to the oral route accelerate the topical drug delivery market growth. The ease of use the system and the extensive use of the drugs to treat diabetic neuropathic pain and foot ulcers further influence the topical drug delivery market. Additionally, ease of use, reduction in overall healthcare cost, increasing incidences of burn injuries, prevalence of diabetes and eye diseases and surge in healthcare expenditure positively affect the topical drug delivery market. Furthermore, rise in demand for self-administration and home care and delivery of biologics through the transdermal route extend profitable opportunities to the topical drug delivery market players in the forecast period of 2021 to 2028.

On the other hand, preference for alternative modes of drug delivery and product recalls due to drug failure are the factors expected to obstruct the topical drug delivery market growth. The technical barriers associated with the skin irritation and permeability is projected to challenge the topical drug delivery market in the forecast period of 2021 to 2028.

This topical drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on topical drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Topical Drug Delivery Market Scope and Market Size

The topical drug delivery market is segmented on the basis of product, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of product, the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations and transdermal products. Semi-solid formulations are further segmented into creams, ointments, lotions, gels and pastes. Liquid formulations are further segmented into solutions and suspensions. Solid formulations are further segmented into powders and suppositories. Transdermal products are further segmented into transdermal patches and transdermal semi-solids.
  • On the basis of route of administration, the topical drug delivery market is segmented into dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery and nasal drug delivery.
  • On the basis of distribution channel, the topical drug delivery market is segmented into direct tenders and retail.
  • On the basis of end-user, the topical drug delivery market is segmented into hospitals, clinics, home healthcare, diagnostic centers and others.

Global Topical Drug Delivery Market Country Level Analysis

The topical drug delivery market is analyzed and market size insights and trends are provided by country, product, route of administration, distribution channel and end-user as referenced above.      

The countries covered in the global topical drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the topical drug delivery market due to the presence of large number of pharmaceutical companies and drug delivery technology providers in the region. Asia-Pacific is expected to witness the highest growth rate during the forecast period of 2021 to 2028 because of the rise in geriatric population and the surge in disposable income of the people.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The topical drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for topical drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the topical drug delivery market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Topical Drug Delivery Market Share Analysis

The topical drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to topical drug delivery market.

The major players covered in topical drug delivery market report are Galderma S.A., GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., Medpharm, 3M, Bayer AG, Novartis AG, Janssen Global Services, LLC, Cipla Inc., West Pharmaceutical Services, Inc, Biofarmitalia s.r.l., Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc, Mylan N.V., Pocono Coated Products LLC, Lohmann Therapie-Systeme AG among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Topical Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLE GLOBAL TOPICAL DRUG DELIVERY MARKET

TABLE 1 LIST OF APPROVED TOPICAL DRUGS TABLE 2 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 3 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 4 GLOBAL TDDF MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 5 GLOBAL LIQUID TDDF MARKET, BY PRODUCT TYPE, 2015– 2024(USD BILLION) TABLE 6 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION) TABLE 7 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION) TABLE 8 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 9 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2014 – 2024 (USD BILLION) TABLE 10 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 11 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION) TABLE 12 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY, 2015 – 2024 (USD BILLION) TABLE 13 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 14 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD BILLION) TABLE 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 16 NORTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 17 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 18 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 19 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD BILLION) TABLE 20 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 21 NORTH AMERICA ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 22 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION) TABLE 23 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD BILLION) TABLE 24 U.S. TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 25 U.S. TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 26 U.S. TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 27 U.S.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 28 U.S.LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 29 U.S.SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 30 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 31 U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 32 CANADA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 33 CANADA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 34 CANADA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 35 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 36 CANADALIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 37 CANADASOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 38 CANADA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 39 CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 40 MEXICO TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 41 MEXICO TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 42 MEXICO TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 43 MEXICOSEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 44 MEXICOLIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 45 MEXICOSOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 46 MEXICO TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 47 MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 48 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 49 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 50 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 51 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 52 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 53 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 54 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 55 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 56 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 57 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 58 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 59 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 60 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 61 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 62 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 63 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 64 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION TABLE 65 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 66 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 67 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 68 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 69 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 70 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 71 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 72 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 73 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 74 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 75 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 76 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 77 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 78 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 79 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 80 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 81 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 82 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 83 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 84 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 85 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 86 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 87 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 88 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 89 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 90 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 91 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 92 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 93 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 94 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 95 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 96 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 97 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 98 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 99 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 100 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 101 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 102 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 103 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 104 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 105 SPAIN TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 106 SPAIN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 107 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 108 NETHERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 109 NETHERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 110 NETHERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 111 NETHERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 112 NETHERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 113 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 114 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 115 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 116 RUSSIA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 117 RUSSIA TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 118 RUSSIA SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 119 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 120 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 121 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 122 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 123 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 124 TURKEY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 125 TURKEY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 126 TURKEY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 127 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 128 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 129 TURKEY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 130 TURKEY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 131 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 132 BELGIUM TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 133 BELGIUM TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 134 BELGIUM SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 135 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 136 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 137 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 138 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION TABLE 139 REST OF EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 140 APAC TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 141 APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 142 APAC TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 143 APAC TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 144 APACSEMI-SOLIDTOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 145 APAC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 146 APAC SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 147 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 148 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 149 APAC TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 150 APAC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 151 JAPAN TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 152 JAPAN. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 153 JAPAN.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 154 JAPAN. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 155 JAPAN. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 156 JAPAN. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 157 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 158 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 159 CHINA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 160 CHINA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 161 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 162 CHINA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 163 CHINA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 164 CHINA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 165 CHINA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 166 CHINA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 167 SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 168 SOUTH KOREA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 169 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 170 SOUTH KOREA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 171 SOUTH KOREA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 172 SOUTH KOREA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 173 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 174 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 175 INDIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 176 INDIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 177 INDIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 178 INDIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 179 INDIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 180 INDIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 181 INDIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024, (USD BILLION) TABLE 182 INDIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 183 AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 184 AUSTRALIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 185 AUSTRALIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 186 AUSTRALIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 187 AUSTRALIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 188 AUSTRALIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 189 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 190 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 191 SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 192 SINGAPORE. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 193 SINGAPORE.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 194 SINGAPORE. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 195 SINGAPORE. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 196 SINGAPORE. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 197 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 198 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 199 THAILAND TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 200 THAILAND. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 201 THAILAND.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 202 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 203 THAILAND. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 204 THAILAND. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 205 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 206 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 207 MALAYSIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 208 MALAYSIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 209 MALAYSIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 210 MALAYSIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 211 MALAYSIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 212 MALAYSIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 213 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024, (USD BILLION) TABLE 214 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 215 INDONESIA TOPICAL DRUG DELIVERY MARKET, BYTYPE, 2015 – 2024 (USD BILLION) TABLE 216 INDONESIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 217 INDONESIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 218 INDONESIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 219 INDONESIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 220 INDONESIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 221 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 222 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 223 PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 224 PHILIPPINES. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 225 PHILIPPINES.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 226 PHILIPPINES. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 227 PHILIPPINES. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION TABLE 228 PHILIPPINES. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 229 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 230 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 231 REST OF APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 232 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 233 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 234 SOUTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 235 SOUTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 236 SOUTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 237 SOUTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 238 SOUTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 239 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 240 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 241 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 242 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 243 BRAZIL TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 244 BRAZIL TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 245 BRAZIL TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 246 BRAZIL SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 247 BRAZIL LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 248 BRAZIL SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 249 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 250 BRAZIL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 251 REST OF SOUTH AMERICA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 252 MEA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 253 MEA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 254 MEA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 255 MEA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 256 MEA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 257 MEA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 258 MEA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE,, 2015 – 2024 (USD BILLION) TABLE 259 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 260 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 261 MEA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 262 MEA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 263 SOUTH AFRICA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 264 SOUTH AFRICA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 265 SOUTH AFRICA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 266 SOUTH AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 267 SOUTH AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 268 SOUTH AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 269 SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 270 SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 271 REST OF MEA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions